1. Taylor FL, Levine LA. Peyronie's disease. Urol Clin North Am. 2007; 34:517–534.
2. Jarow JP, Lowe FC. Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. J Urol. 1997; 158:1388–1390.
3. Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie's lesion. J Urol. 1997; 157:285–290.
4. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J Urol. 1990; 144:1376–1379.
5. Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie's disease. J Urol. 2006; 175:2115–2118.
6. Kadioglu A, Sanli O, Akman T, Canguven O, Aydin M, Akbulut F, et al. Factors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patients. J Androl. 2011; 32:502–508.
7. Hatzimouratidis K, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Salonia A, et al. EAU guidelines on penile curvature. Eur Urol. 2012; 62:543–552.
8. Muller A, Mulhall JP. Peyronie's disease intervention trials: methodological challenges and issues. J Sex Med. 2009; 6:848–861.
9. El-Sakka AI, Yassin AA. Conservative treatment for Peyronie's disease: an update. Expert Opin Pharmacother. 2008; 9:53–63.
10. Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. J Sex Med. 2008; 5:1468–1473.
11. Gontero P, Di Marco M, Giubilei G, Bartoletti R, Pappagallo G, Tizzani A, et al. Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease Results of a phase II prospective study. J Sex Med. 2009; 6:558–566.
12. LaRochelle JC, Levine LA. A Survey of primary-care physicians and urologists regarding Peyronie's disease. J Sex Med. 2007; 4(4 Pt 2):1167–1173.
13. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001; 88:727–730.
14. Kadioglu A, Sanli O. Epidemiology of Peyronie's disease. In : Levine LA, editor. Peyronie's disease: a guide to clinical management. Totowa (NJ): Humana Press;2007. p. 9–18.
15. Chung E, Clendinning E, Lessard L, Brock G. Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. J Sex Med. 2011; 8:594–600.
16. Benson JS, Abern MR, Levine LA. Penile shortening after radical prostatectomy and Peyronie's surgery. Curr Urol Rep. 2009; 10:468–474.
17. Weidner W, Hauck EW, Schnitker J. Peyronie's Disease Study Group of Andrological Group of German Urologists. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Eur Urol. 2005; 47:530–535.
18. Pryor JP, Farell CR. Controlled clinical trial of vitamin E in Peyronie's disease. Prog Reprod Biol Med. 1983; 9:41–45.
19. Lemourt Oliva M, Filgueiras Lopez E, Rodriguez Barroso A, Gonzalez Oramas E, Bordonado R. Clinical evaluation of the use of propoleum in Peyronie's disease. Arch Esp Urol. 1998; 51:171–176.
20. Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol. 1999; 162:2003–2005.
21. Safarinejad MR. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. Int J Impot Res. 2004; 16:238–243.
22. Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int. 2001; 88:63–67.
23. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. J Urol. 2007; 178(4 Pt 1):1398–1403.
24. Ryu JK, Suh JK. Peyronie's disease: current medical treatment and future perspectives. Korean J Urol. 2009; 50:527–533.
25. Shirazi M, Haghpanah AR, Badiee M, Afrasiabi MA, Haghpanah S. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study. Int Urol Nephrol. 2009; 41:467–471.
26. Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States. Adv Urol. 2011; 2011:282503.
27. Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO. GSSAB Investigators' Group. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int. 2005; 95:609–614.